English Overview
This educational activity focuses on the management of patients with Obstructive Sleep Apnea (OSA) and obesity and discussing the new data release of Heart Failure with Preserved Ejection Fraction (HFpEF) with Mounjaro , highlighting early intervention strategies and emerging treatment options through expert insights and case-based discussion (many real live cases are included !
This Activity for
- Resident / Fellow
- Physician
- Clinical Pharmacy
What I will learn?
By the end of this activity, participants will be able to:
- Review the evolving role of tirzepatide across T2D and CWM in congestion with the patients who have OSA and HFpEF
- Apply clinical evidence to real-world patient care
Speakers
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
|
Advocating for Better Obesity Care With Tirzepatide: New Data Release on OSA!
Certificate |
Certificate | Free |
